These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 9209504)

  • 21. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
    St-Pierre Y; Watts TH
    J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major histocompatibility complex non-restricted presentation to CD4+ T lymphocytes of Mycobacterium leprae heat-shock protein 65 antigen by macrophages transfected with the mycobacterial gene.
    Silva CL; Lukacs K; Lowrie DB
    Immunology; 1993 Jan; 78(1):35-42. PubMed ID: 7679662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
    Nabavieh A; Chou H; Volokhov I; Lee JE; Purdy LE; Elliott JF; Singh B; Madrenas J
    J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation.
    La Flamme AC; Kahn SJ; Rudensky AY; Van Voorhis WC
    Eur J Immunol; 1997 Dec; 27(12):3085-94. PubMed ID: 9464791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
    Kovacsovics-Bankowski M; Rock KL
    Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC; Steele CR; Gu L; Song W; Pierce SK
    J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells.
    Weber DA; Buck LB; Delohery TM; Agostino N; Pernis B
    J Mol Cell Immunol; 1990; 4(5):255-66; discussion 266-8. PubMed ID: 2169757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eosinophil as antigen-presenting cell: activation of T cell clones and T cell hybridoma by eosinophils after antigen processing.
    Del Pozo V; De Andrés B; Martín E; Cárdaba B; Fernández JC; Gallardo S; Tramón P; Leyva-Cobian F; Palomino P; Lahoz C
    Eur J Immunol; 1992 Jul; 22(7):1919-25. PubMed ID: 1623930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
    J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
    Matousek MP; Nedrud JG; Harding CV
    J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
    St Pierre Y; Watts TH
    J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Ag-presenting cells in the conjunctiva during the development of experimental immune-mediated blepharoconjunctivitis.
    Ozaki A; Fukushima A; Ishida W; Zinchuk O; Fukata K; Hayashi Y; Enzan H; Takata M; Yagita H; Ueno H
    Curr Eye Res; 2004; 29(4-5):277-86. PubMed ID: 15590473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
    Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
    Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular interference with antigen presentation.
    Leyva-Cobian F; Unanue ER
    J Immunol; 1988 Sep; 141(5):1445-50. PubMed ID: 3137257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.